Home › Funds › Empery Asset Management, LP › MSLE
Empery Asset Management, LP position in MSLE
SATELLOS BIOSCIENCE INC · Health Care
Empery Asset Management, LP reported holding 107,100 shares of MSLE (SATELLOS BIOSCIENCE INC) in its Q2 2026 13F filing — a position valued at US$833K, representing 0.96% of its reported portfolio and ranking #15 among its reported holdings. Empery Asset Management, LP has disclosed MSLE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Empery Asset Management, LP's MSLE position evolved
Empery Asset Management, LP first disclosed a stake in MSLE in Q1 2026 at 230,100 shares (US$1.3M). Across 2 filings, Empery Asset Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 107,100 shares valued at US$833K — a reduction of -123,000 shares quarter over quarter.. Notable position changes include a 53% trim in Q2 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 230.10K | $1.30M | New |
| Q2 2026 | 107.10K | $832.70K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MSLE and 13F data
MSLE (SATELLOS BIOSCIENCE INC) is a Health Care company. 27 other funds we track also report a position in MSLE — the largest reported positions include Vivo Capital, LLC (US$6.3M), SPHERA FUNDS MANAGEMENT LTD. (US$5.1M), Stonepine Capital Management, LLC (US$3.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MSLE
- Vivo Capital, LLC 813.67K sh · $6.33M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 652.59K sh · $5.07M · Q2 2026
- Stonepine Capital Management, LLC 491.62K sh · $3.72M · Q2 2026
- Avidity Partners Management LP 387.77K sh · $3.01M · Q2 2026
- Saturn V Capital Management LP 350.00K sh · $2.72M · Q2 2026
More on Empery Asset Management, LP
FAQ
How long has Empery Asset Management, LP held MSLE?
Empery Asset Management, LP has disclosed MSLE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Empery Asset Management, LP's current position in MSLE?
As of Q2 2026, Empery Asset Management, LP holds 107.10K shares of MSLE (SATELLOS BIOSCIENCE INC), valued at $832.70K, representing 0.96% of its reported portfolio and ranking #15.
Has Empery Asset Management, LP been buying or selling MSLE?
In the latest 13F filing (Q2 2026), Empery Asset Management, LP reduced its position in MSLE.
Which other funds hold MSLE?
Other major institutional holders of MSLE include Vivo Capital, LLC, SPHERA FUNDS MANAGEMENT LTD., Stonepine Capital Management, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.